(Translated by https://www.hiragana.jp/)
Press Releases • CureSearch for Children's Cancer

Press Releases

Home » Press Releases

FDA Grants Approval of New Pediatric Glioma Drug to Day One, a Biopharma Co-founded by CureSearch Board Member Dr. Samuel Blackman

Pediatric low-grade glioma (pLGG) is the most common form of pediatric brain cancer. Day One’s OJEMDA™ is the first targeted treatment for pLGG tumors with BRAF fusions and mutations. Last week, on April 23, 2024, Day One Biopharmaceuticals was granted Accelerated

FDA Grants Approval of New Pediatric Glioma Drug to Day One, a Biopharma Co-founded by CureSearch Board Member Dr. Samuel Blackman Read More »

CureSearch to lead impact study on cost, treatment benefits of molecular testing for childhood cancer patients

Bethesda, Md. – January 18, 2023 – CureSearch for Children’s Cancer, a national nonprofit dedicated to ensuring that every child diagnosed with cancer has a safe and effective treatment option, will lead a healthcare economic study to determine how molecular testing

CureSearch to lead impact study on cost, treatment benefits of molecular testing for childhood cancer patients Read More »

CureSearch for Children’s Cancer receives gift to support promising immunotherapy trial

Funds to support cutting-edge immunotherapy trial for pediatric high-grade glioma  Bethesda, MD – February 8, 2020  – CureSearch for Children’s Cancer has received a $1 million gift from the Norcross Family Foundation in support of a first-in-human, phase I/II clinical trial testing

CureSearch for Children’s Cancer receives gift to support promising immunotherapy trial Read More »

Elias Sayour, MD, PhD

Newly-funded CureSearch and SebastianStrong Foundation project aims to develop immunotherapy treatment for pediatric leukemia

FOR IMMEDIATE RELEASE Media Contact: Margetta Thomas, Communications Manager margetta.thomas@curesearch.org    Novel immunotherapy approach could improve survival rate for acute myeloid leukemia Bethesda, Md. – September 15, 2021 – CureSearch for Children’s Cancer, in partnership with the SebastianStrong Foundation, has awarded a three-year, $270,650 CureSearch Young Investigator grant

Newly-funded CureSearch and SebastianStrong Foundation project aims to develop immunotherapy treatment for pediatric leukemia Read More »

Leaders in pediatric oncology converge to improve the next decade of clinical trials

FOR IMMEDIATE RELEASE Media Contact: Margetta Thomas, Communications Manager margetta.thomas@curesearch.org  Collaborative forum to address the unique aspects and challenges of pediatric cancer clinical trial design  Bethesda, MD – September 9, 2021 – CureSearch for Children’s Cancer will host the virtual 2021 Pediatric Early Development Symposium (PEDS) – Pediatric

Leaders in pediatric oncology converge to improve the next decade of clinical trials Read More »

Pin It on Pinterest

Scroll to Top